PURA - Puration Pursues Bay Street Cannabis Valuation Even Though Trump Indicates Lifting US Marijuana Ban
June 12 2018 - 10:50AM
InvestorsHub NewsWire
PURA - Puration Pursues Bay
Street Cannabis Valuation Even Though Trump Indicates Lifting US
Marijuana Ban
Dallas, TX. -- June 12, 2018 -- InvestorsHub
NewsWire -- Puration, Inc. (USOTC:
PURA) plans to spin-off its cannabis cultivation business into
a standalone, independently traded company listed both in Canada
and the US. The planned transaction includes a dividend
distribution of shares in the independently traded spin-off company
to the shareholders of Puration.
“We
are certainly excited about
President Trump’s recent statements regarding the nationwide
lifting of the federal ban on marijuana,” said Brian Shibley, CEO
of Puration. “However, we anticipate such a lifting will take some
time. In the meantime, Canada is several steps ahead in
legalizing recreational marijuana nationwide and in conjunction
with Canadian legalization, Bay Street offers a far more optimistic
valuation of marijuana stocks than Wall Street. Better
valuations in turn present cannabis companies with capital cost
benefits. Accordingly, we have acquired a cannabis
cultivation business in Canada that is an important part of our
overall cultivation strategy and we will include a Canadian listing
in the cultivation spin-off.”
Puration will continue to expand its cannabis
infused beverage business separate from the cannabis cultivation
spin-off. Last year, PURA introduced EVERx CBD Infused Sports
Water as an evolution of the company’s cannabis extraction
business. EVERx has since become a recognized brand in sports
nutrition market place. Distribution is growing. PURA
has recently designed a THC infused beverage named THCSavor
expected to be introduced in Canada later this
year.
For more information
on Puration, visit http://www.aciconglomerated.com.
Disclaimer/Safe
Harbor:
This news release
contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the
Company's current views with respect to future events that involve
risks and uncertainties. Among others, these risks include the
expectation that any of the companies mentioned herein will achieve
significant sales, the failure to meet schedule or performance
requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the
emergence of competitors with greater financial resources and the
impact of competitive pricing. In the light of these uncertainties,
the forward-looking events referred to in this release might not
occur. These statements have not been evaluated by the Food and
Drug Administration. These products are not intended to diagnose,
treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
+1-800-861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Apr 2023 to Apr 2024